File(s) under permanent embargo
Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation
journal contribution
posted on 2023-05-21, 03:25 authored by Woldesellassie BezabheWoldesellassie Bezabhe, Luke BereznickiLuke Bereznicki, Janette RadfordJanette Radford, Mohammed SalahudeenMohammed Salahudeen, Edward Garrahy, Barbara Wimmer, Ivan BindoffIvan Bindoff, Gregory PetersonGregory PetersonDespite changes in antiarrhythmic drug (AAD) choice in patients with atrial fibrillation (AF), trends in AAD prescribing remain not investigated. We aimed to examine these changes using a nationwide Australian general practice data from 2009 to 2018. Over the 10 years, AAD prescribing in patients with AF decreased, which was mainly due to a reduction in the use of amiodarone, sotalol and digoxin. In contrast, the use of beta-blockers and flecainide increased.
History
Publication title
Internal Medicine JournalVolume
51Issue
10Pagination
1732-1735ISSN
1444-0903Department/School
School of Pharmacy and PharmacologyPublisher
Blackwell Publishing AsiaPlace of publication
54 University St, P O Box 378, Carlton, Australia, Victoria, 3053Rights statement
© 2021 Royal Australasian College of PhysiciansRepository Status
- Restricted